v3.21.2
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:    
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 96,584 $ (50,494)
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, Amortization And Non-Cash Lease Expense 60,962 65,924
Accounts Receivable, Credit Loss Expense (Reversal) (9,757) 22,815
Loss on disposal or impairment of property, plant, and equipment 201 8,800
Deferred income taxes (9,667) 4,362
Share-based Payment Arrangement, Noncash Expense 9,823 7,712
Changes in operating assets and liabilities:    
Increase (Decrease) in Accounts Receivable 180,456 244,112
Increase (Decrease) in Inventories (123,737) (202,646)
Increase (Decrease) in Prepaid Expense and Other Assets (48,160) (3,199)
Increase (Decrease) in Other Operating Assets (337) (14,596)
Increase (Decrease) in Accounts Payable 59,085 3,397
Increase (Decrease) in Accrued Liabilities (30,130) (89,323)
Increase (Decrease) in Income Taxes Payable (22,652) (12,633)
Increase (Decrease) In Operating Lease, Right-Of-Use Assets And Liabilities (47,436) (26,264)
Other liabilities 1,927 4,757
Net cash provided by operating activities 117,162 (37,276)
Cash flows from investing activities:    
Payments to Acquire Short-term Investments 0 (35,045)
Proceeds from Sale, Maturity and Collection of Short-term Investments 1,184 36,631
Payments to Acquire Property, Plant, and Equipment (12,387) (20,959)
Net cash used in investing activities (11,203) (19,373)
Cash flows from financing activities:    
Proceeds from Lines of Credit 19,888 375,759
Repayments of Lines of Credit (19,683) (373,390)
Debt Issuance Costs, Line of Credit Arrangements, Gross 0 (1,674)
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 20,287 1,987
Payment, Tax Withholding, Share-based Payment Arrangement (5,440) (4,304)
Payments for Repurchase of Common Stock (54,500) (132,889)
Payments of Ordinary Dividends, Common Stock (34,540) (17,195)
Net cash used in financing activities (73,988) (151,706)
Effect of Exchange Rate on Cash and Cash Equivalents (2,890) (2,861)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total 29,081 (211,216)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning Balance 790,725 686,009
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 819,806 474,793
Supplemental disclosures of cash flow information:    
Income Taxes Paid 81,497 13,294
Supplemental disclosures of non-cash investing activities:    
Capital expenditures incurred but not yet paid $ 4,268 $ 2,414

Source